Bio-Rad Labs (BIO) Misses Q3 EPS by 18c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $276.96 -1.48%
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.60, $0.18 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $680.8 million versus the consensus estimate of $679.94 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- AMC Entertainment prices $200M stock offering to redeem senior notes
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
